In addition, a strong DNA damage increase was also detected in SR‐4835‐treated CRC cells and HCT116 subcutaneous tumours from either SR‐4835‐treatment or the CDK12‐knockdown group as reflected by the protein levels of γ‐H2AX (Figure S7A–C). The gene discussed is CDK12; the disease is neoplasm.